Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice Regulations for Medicated Feeds, 7741-7743 [2023-02446]

Download as PDF Federal Register / Vol. 88, No. 24 / Monday, February 6, 2023 / Notices Dated: February 1, 2023. Lauren K. Roth, Associate Commissioner for Policy. [FR Doc. 2023–02482 Filed 2–3–23; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2010–N–0601] Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice Regulations for Medicated Feeds AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the recordkeeping requirements for manufacturers of medicated animal feeds. DATES: Either electronic or written comments on the collection of information must be submitted by April 7, 2023. ADDRESSES: You may submit comments as follows. Please note that late, untimely filed comments will not be considered. The https:// www.regulations.gov electronic filing system will accept comments until 11:59 p.m. Eastern Time at the end of April 7, 2023. Comments received by mail/hand delivery/courier (for written/ paper submissions) will be considered timely if they are received on or before that date. DDrumheller on DSK120RN23PROD with NOTICES SUMMARY: Electronic Submissions Submit electronic comments in the following way: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https:// www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your VerDate Sep<11>2014 18:51 Feb 03, 2023 Jkt 259001 comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else’s Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov. • If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ‘‘Written/Paper Submissions’’ and ‘‘Instructions’’). Written/Paper Submissions Submit written/paper submissions as follows: • Mail/Hand Delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. • For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in ‘‘Instructions.’’ Instructions: All submissions received must include the Docket No. FDA– 2010–N–0601 for ‘‘Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice Regulations for Medicated Feeds.’’ Received comments, those filed in a timely manner (see ADDRESSES), will be placed in the docket and, except for those submitted as ‘‘Confidential Submissions,’’ publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday, 240–402–7500. • Confidential Submissions—To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states ‘‘THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.’’ The Agency will review this copy, including the claimed confidential information, in its consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 7741 https://www.regulations.gov. Submit both copies to the Dockets Management Staff. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as ‘‘confidential.’’ Any information marked as ‘‘confidential’’ will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA’s posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: https:// www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf. Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to https:// www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the ‘‘Search’’ box and follow the prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, 240–402–7500. FOR FURTHER INFORMATION CONTACT: Amber Sanford, Office of Operations, Food and Drug Administration, Three White Flint North, 10A–12M, 11601 Landsdown St., North Bethesda, MD 20852, 301–796–8867, PRAStaff@ fda.hhs.gov. SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501–3521), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. ‘‘Collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes Agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, FDA is publishing notice of the proposed collection of information set forth in this document. With respect to the following collection of information, FDA invites comments on these topics: (1) whether the proposed collection of information is necessary for the proper performance of FDA’s functions, including whether the information will have practical utility; (2) the accuracy of FDA’s E:\FR\FM\06FEN1.SGM 06FEN1 7742 Federal Register / Vol. 88, No. 24 / Monday, February 6, 2023 / Notices estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, when appropriate, and other forms of information technology. Current Good Manufacturing Practice Regulations for Medicated Feeds—21 CFR Part 225 OMB Control Number 0910–0152— Extension Under section 501 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 351), FDA has the statutory authority to issue current good manufacturing practice (CGMP) regulations for drugs, including medicated feeds. Medicated feeds are administered to animals for the prevention, cure, mitigation, or treatment of disease, or growth criteria in part 225 to determine whether the systems and procedures used by manufacturers of medicated feeds are adequate to ensure that their feeds meet the requirements of the FD&C Act as to safety, and also that they meet their claimed identity, strength, quality, and purity, as required by section 501(a)(2)(B) of the FD&C Act. promotion and feed efficiency. Statutory requirements for CGMPs have been codified under part 225 (21 CFR part 225). Medicated feeds that are not manufactured in accordance with these regulations are considered adulterated under section 501(a)(2)(B) of the FD&C Act. Under part 225, a manufacturer is required to establish, maintain, and retain records for a medicated feed, including records to document procedures required during the manufacturing process to assure that proper quality control is maintained. Such records would, for example, contain information concerning receipt and inventory of drug components, batch production, laboratory assay results (i.e., batch and stability testing), labels, and product distribution. This information is needed so that FDA can monitor drug usage and possible misformulation of medicated feeds to investigate violative drug residues in products from treated animals and to investigate product defects when a drug is recalled. In addition, FDA will use the CGMP A license is required when the manufacturer of a medicated feed involves the use of a drug or drugs that FDA has determined requires more control because of the need for a withdrawal period before slaughter or because of carcinogenic concerns. Conversely, a license is not required, and the recordkeeping requirements are less demanding, for those medicated feeds for which FDA has determined that the drugs used in their manufacture need less control. Respondents to this collection of information are commercial feed mills and mixers/ feeders. FDA estimates the burden of this collection of information as follows: TABLE 1—ESTIMATED ANNUAL RECORDKEEPING BURDEN—REGISTERED LICENSED COMMERCIAL FEED MILLS 1 Number of respondents 21 CFR part Number of responses per respondent Total annual responses Average burden per response Total hours 225.42(b)(5) through (8) requires records of receipt, storage, and inventory control of medicated feeds. 225.58(c) and (d) requires records of the results of periodic assays for medicated feeds that are in accord with label specifications and also those medicated feeds not within documented permissible assay limits. 225.80(b)(2) requires that verified medicated feed label(s) be kept for 1 year. 225.102(b)(1) through (5), requires records of master record files and production records for medicated feeds. 225.110(b)(1) and (2) requires maintenance of distribution records for medicated feeds. 225.115(b)(1) and (2) requires maintenance of complaint files by the medicated feed manufacturer. 791 260 205,660 1 .................................. 205,660 791 45 35,595 0.50 (30 minutes) ....... 17,798 791 1,600 1,265,600 0.12 (7 minutes) ......... 151,872 791 7,800 6,169,800 0.08 (5 minutes) ......... 493,584 791 7,800 6,169,800 0.02 (1 minute) ........... 123,396 791 5 3,955 0.12 (7 minutes) ......... 475 Total ...................................................................................................... ........................ ........................ ........................ ..................................... 992,785 1 There are no capital costs or operating and maintenance costs associated with this collection of information. TABLE 2—ESTIMATED ANNUAL RECORDKEEPING BURDEN—REGISTERED LICENSED MIXER/FEEDERS 1 DDrumheller on DSK120RN23PROD with NOTICES Number of records per recordkeeper Number of recordkeepers 21 CFR part Total annual records Average burden per recordkeeping Total hours 225.42(b)(5) through (8) requires records of receipt, storage, and inventory control of medicated feeds. 225.58(c) and (d) requires records of the results of periodic assays for medicated feeds that are in accord with label specifications and also those medicated feeds not within documented permissible assay limits. 225.80(b)(2) requires that verified medicated feed label(s) be kept for 1 year. 225.102(b)(1) through (5) requires records of master record files and production records for medicated feeds. 100 260 26,000 0.15 (9 minutes) ......... 3,900 100 36 3,600 0.50 (30 minutes) ....... 1,800 100 48 4,800 0.12 (7 minutes) ......... 576 100 260 26,000 0.40 (24 minutes) ....... 10,400 Total ...................................................................................................... ........................ ........................ ........................ ..................................... 16,676 1 There are no capital costs or operating and maintenance costs associated with this collection of information. VerDate Sep<11>2014 18:51 Feb 03, 2023 Jkt 259001 PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 E:\FR\FM\06FEN1.SGM 06FEN1 7743 Federal Register / Vol. 88, No. 24 / Monday, February 6, 2023 / Notices TABLE 3—ESTIMATED ANNUAL RECORDKEEPING BURDEN—NONREGISTERED NON-LICENSED COMMERCIAL FEED MILLS 1 Number of records per recordkeeper Number of recordkeepers 21 CFR section Total annual records Average burden per recordkeeping Total hours 225.142 requires procedures for identification, storage, and inventory control (receipt and use) of Type A medicated articles and Type B medicated feeds. 225.158 requires records of investigation and corrective action when the results of laboratory assays of drug components indicate that the medicated feed is not in accord with the permissible assay limits. 225.180 requires identification, storage, and inventory control of labeling in a manner that prevents label mix-ups and assures that correct labels are used for medicated feeds. 225.202 requires records of formulation, production, and distribution of medicated feeds. 4,357 4 17,428 1 .................................. 17,428 4,357 1 4,357 4 .................................. 17,428 4,357 96 418,272 0.12 (7 minutes) ......... 50,193 4,357 260 1,132,820 0.65 (39 minutes) ....... 736,333 Total ...................................................................................................... ........................ ........................ ........................ ..................................... 821,382 1 There are no capital costs or operating and maintenance costs associated with this collection of information. TABLE 4—ESTIMATED ANNUAL RECORDKEEPING BURDEN—NONREGISTERED NON-LICENSED MIXER/FEEDERS 1 Total annual records Average burden per recordkeeper Total hours 225.142 requires procedures for identification, storage, and inventory control (receipt and use) of Type A medicated articles and Type B medicated feeds. 225.158 requires records of investigation and corrective action when the results of laboratory assays of drug components indicate that the medicated feed is not in accord with the permissible assay limits. 225.180 requires identification, storage, and inventory control of labeling in a manner that prevents label mix-ups and assures that correct labels are used for medicated feeds. 225.202 requires records of formulation, production, and distribution of medicated feeds. 3,400 4 13,600 1 .................................. 13,600 3,400 1 3,400 4 .................................. 13,600 3,400 32 108,800 0.12 (7 minutes) ......... 13,056 3,400 260 884,000 0.33 (20 minutes) ....... 291,720 Total ...................................................................................................... ........................ ........................ ........................ ..................................... 331,976 1 There are no capital costs or operating and maintenance costs associated with this collection of information. Our estimated burden for the information collection reflects an overall decrease of 10,435 hours and an increase of 831,545 records since last OMB approval. We attribute this adjustment due to an increase in the number of non-registered, non-licensed commercial medicated feed mills and decrease in non-licensed medicated feed mill recordkeeping the last few years. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Dated: February 1, 2023. Lauren K. Roth, Associate Commissioner for Policy. Name of Committee: National Center for Complementary and Integrative Health Special Emphasis Panel; Research Resource Center to Build an Open-Access Repository and Database for Anatomical and Physiological Correlates of Acupoints (U24, Clinical Trial Optional). Date: March 3, 2023. Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Center for Complementary and Integrative Democracy II, 6707 Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting). Contact Person: Shiyong Huang, Ph.D., Scientific Review Officer, Office of Scientific Review, Division of Extramural Activities, NCCIH/NIH, 6707 Democracy Boulevard, Suite 401, Bethesda, MD 20817, shiyong.huang@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.213, Research and Training [FR Doc. 2023–02446 Filed 2–3–23; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health DDrumheller on DSK120RN23PROD with NOTICES Number of records per recordkeeper Number of recordkeepers 21 CFR section National Center for Complementary & Integrative Health; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections VerDate Sep<11>2014 18:51 Feb 03, 2023 Jkt 259001 PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 in Complementary and Alternative Medicine, National Institutes of Health, HHS) Dated: February 1, 2023. Victoria E. Townsend, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–02462 Filed 2–3–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; 30-Day Comment Request; Information Program on Clinical Trials: Maintaining a Registry and Results Databank (National Library of Medicine) AGENCY: National Institutes of Health, HHS. ACTION: Notice. In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. SUMMARY: E:\FR\FM\06FEN1.SGM 06FEN1

Agencies

[Federal Register Volume 88, Number 24 (Monday, February 6, 2023)]
[Notices]
[Pages 7741-7743]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-02446]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0601]


Agency Information Collection Activities; Proposed Collection; 
Comment Request; Current Good Manufacturing Practice Regulations for 
Medicated Feeds

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing 
an opportunity for public comment on the proposed collection of certain 
information by the Agency. Under the Paperwork Reduction Act of 1995 
(PRA), Federal agencies are required to publish notice in the Federal 
Register concerning each proposed collection of information, including 
each proposed extension of an existing collection of information, and 
to allow 60 days for public comment in response to the notice. This 
notice solicits comments on the recordkeeping requirements for 
manufacturers of medicated animal feeds.

DATES: Either electronic or written comments on the collection of 
information must be submitted by April 7, 2023.

ADDRESSES: You may submit comments as follows. Please note that late, 
untimely filed comments will not be considered. The https://www.regulations.gov electronic filing system will accept comments until 
11:59 p.m. Eastern Time at the end of April 7, 2023. Comments received 
by mail/hand delivery/courier (for written/paper submissions) will be 
considered timely if they are received on or before that date.

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments. Comments submitted 
electronically, including attachments, to https://www.regulations.gov 
will be posted to the docket unchanged. Because your comment will be 
made public, you are solely responsible for ensuring that your comment 
does not include any confidential information that you or a third party 
may not wish to be posted, such as medical information, your or anyone 
else's Social Security number, or confidential business information, 
such as a manufacturing process. Please note that if you include your 
name, contact information, or other information that identifies you in 
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential 
information that you do not wish to be made available to the public, 
submit the comment as a written/paper submission and in the manner 
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand Delivery/Courier (for written/paper 
submissions): Dockets Management Staff (HFA-305), Food and Drug 
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets 
Management Staff, FDA will post your comment, as well as any 
attachments, except for information submitted, marked and identified, 
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No. 
FDA-2010-N-0601 for ``Agency Information Collection Activities; 
Proposed Collection; Comment Request; Current Good Manufacturing 
Practice Regulations for Medicated Feeds.'' Received comments, those 
filed in a timely manner (see ADDRESSES), will be placed in the docket 
and, except for those submitted as ``Confidential Submissions,'' 
publicly viewable at https://www.regulations.gov or at the Dockets 
Management Staff between 9 a.m. and 4 p.m., Monday through Friday, 240-
402-7500.
     Confidential Submissions--To submit a comment with 
confidential information that you do not wish to be made publicly 
available, submit your comments only as a written/paper submission. You 
should submit two copies total. One copy will include the information 
you claim to be confidential with a heading or cover note that states 
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will 
review this copy, including the claimed confidential information, in 
its consideration of comments. The second copy, which will have the 
claimed confidential information redacted/blacked out, will be 
available for public viewing and posted on https://www.regulations.gov. 
Submit both copies to the Dockets Management Staff. If you do not wish 
your name and contact information to be made publicly available, you 
can provide this information on the cover sheet and not in the body of 
your comments and you must identify this information as 
``confidential.'' Any information marked as ``confidential'' will not 
be disclosed except in accordance with 21 CFR 10.20 and other 
applicable disclosure law. For more information about FDA's posting of 
comments to public dockets, see 80 FR 56469, September 18, 2015, or 
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or 
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in 
the heading of this document, into the ``Search'' box and follow the 
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, 
Rm. 1061, Rockville, MD 20852, 240-402-7500.

FOR FURTHER INFORMATION CONTACT: Amber Sanford, Office of Operations, 
Food and Drug Administration, Three White Flint North, 10A-12M, 11601 
Landsdown St., North Bethesda, MD 20852, 301-796-8867, 
[email protected].

SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3521), Federal 
agencies must obtain approval from the Office of Management and Budget 
(OMB) for each collection of information they conduct or sponsor. 
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 
1320.3(c) and includes Agency requests or requirements that members of 
the public submit reports, keep records, or provide information to a 
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) 
requires Federal agencies to provide a 60-day notice in the Federal 
Register concerning each proposed collection of information, including 
each proposed extension of an existing collection of information, 
before submitting the collection to OMB for approval. To comply with 
this requirement, FDA is publishing notice of the proposed collection 
of information set forth in this document.
    With respect to the following collection of information, FDA 
invites comments on these topics: (1) whether the proposed collection 
of information is necessary for the proper performance of FDA's 
functions, including whether the information will have practical 
utility; (2) the accuracy of FDA's

[[Page 7742]]

estimate of the burden of the proposed collection of information, 
including the validity of the methodology and assumptions used; (3) 
ways to enhance the quality, utility, and clarity of the information to 
be collected; and (4) ways to minimize the burden of the collection of 
information on respondents, including through the use of automated 
collection techniques, when appropriate, and other forms of information 
technology.

Current Good Manufacturing Practice Regulations for Medicated Feeds--21 
CFR Part 225

OMB Control Number 0910-0152--Extension

    Under section 501 of the Federal Food, Drug, and Cosmetic Act (FD&C 
Act) (21 U.S.C. 351), FDA has the statutory authority to issue current 
good manufacturing practice (CGMP) regulations for drugs, including 
medicated feeds. Medicated feeds are administered to animals for the 
prevention, cure, mitigation, or treatment of disease, or growth 
promotion and feed efficiency. Statutory requirements for CGMPs have 
been codified under part 225 (21 CFR part 225). Medicated feeds that 
are not manufactured in accordance with these regulations are 
considered adulterated under section 501(a)(2)(B) of the FD&C Act. 
Under part 225, a manufacturer is required to establish, maintain, and 
retain records for a medicated feed, including records to document 
procedures required during the manufacturing process to assure that 
proper quality control is maintained. Such records would, for example, 
contain information concerning receipt and inventory of drug 
components, batch production, laboratory assay results (i.e., batch and 
stability testing), labels, and product distribution.
    This information is needed so that FDA can monitor drug usage and 
possible misformulation of medicated feeds to investigate violative 
drug residues in products from treated animals and to investigate 
product defects when a drug is recalled. In addition, FDA will use the 
CGMP criteria in part 225 to determine whether the systems and 
procedures used by manufacturers of medicated feeds are adequate to 
ensure that their feeds meet the requirements of the FD&C Act as to 
safety, and also that they meet their claimed identity, strength, 
quality, and purity, as required by section 501(a)(2)(B) of the FD&C 
Act.
    A license is required when the manufacturer of a medicated feed 
involves the use of a drug or drugs that FDA has determined requires 
more control because of the need for a withdrawal period before 
slaughter or because of carcinogenic concerns. Conversely, a license is 
not required, and the recordkeeping requirements are less demanding, 
for those medicated feeds for which FDA has determined that the drugs 
used in their manufacture need less control. Respondents to this 
collection of information are commercial feed mills and mixers/feeders.
    FDA estimates the burden of this collection of information as 
follows:

                              Table 1--Estimated Annual Recordkeeping Burden--Registered Licensed Commercial Feed Mills \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                    Number of
                  21 CFR part                       Number of     responses per   Total annual           Average burden per response         Total hours
                                                   respondents     respondent       responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
225.42(b)(5) through (8) requires records of                791             260         205,660  1.........................................      205,660
 receipt, storage, and inventory control of
 medicated feeds.
225.58(c) and (d) requires records of the                   791              45          35,595  0.50 (30 minutes).........................       17,798
 results of periodic assays for medicated feeds
 that are in accord with label specifications
 and also those medicated feeds not within
 documented permissible assay limits.
225.80(b)(2) requires that verified medicated               791           1,600       1,265,600  0.12 (7 minutes)..........................      151,872
 feed label(s) be kept for 1 year.
225.102(b)(1) through (5), requires records of              791           7,800       6,169,800  0.08 (5 minutes)..........................      493,584
 master record files and production records for
 medicated feeds.
225.110(b)(1) and (2) requires maintenance of               791           7,800       6,169,800  0.02 (1 minute)...........................      123,396
 distribution records for medicated feeds.
225.115(b)(1) and (2) requires maintenance of               791               5           3,955  0.12 (7 minutes)..........................          475
 complaint files by the medicated feed
 manufacturer.
                                                --------------------------------------------------------------------------------------------------------
    Total......................................  ..............  ..............  ..............  ..........................................      992,785
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.


                                  Table 2--Estimated Annual Recordkeeping Burden--Registered Licensed Mixer/Feeders \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                    Number of
                  21 CFR part                       Number of      records per    Total annual        Average burden per recordkeeping       Total hours
                                                  recordkeepers   recordkeeper       records
--------------------------------------------------------------------------------------------------------------------------------------------------------
225.42(b)(5) through (8) requires records of                100             260          26,000  0.15 (9 minutes)..........................        3,900
 receipt, storage, and inventory control of
 medicated feeds.
225.58(c) and (d) requires records of the                   100              36           3,600  0.50 (30 minutes).........................        1,800
 results of periodic assays for medicated feeds
 that are in accord with label specifications
 and also those medicated feeds not within
 documented permissible assay limits.
225.80(b)(2) requires that verified medicated               100              48           4,800  0.12 (7 minutes)..........................          576
 feed label(s) be kept for 1 year.
225.102(b)(1) through (5) requires records of               100             260          26,000  0.40 (24 minutes).........................       10,400
 master record files and production records for
 medicated feeds.
                                                --------------------------------------------------------------------------------------------------------
    Total......................................  ..............  ..............  ..............  ..........................................       16,676
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.


[[Page 7743]]


                          Table 3--Estimated Annual Recordkeeping Burden--Nonregistered Non-Licensed Commercial Feed Mills \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                    Number of
                 21 CFR section                     Number of      records per    Total annual        Average burden per recordkeeping       Total hours
                                                  recordkeepers   recordkeeper       records
--------------------------------------------------------------------------------------------------------------------------------------------------------
225.142 requires procedures for identification,           4,357               4          17,428  1.........................................       17,428
 storage, and inventory control (receipt and
 use) of Type A medicated articles and Type B
 medicated feeds.
225.158 requires records of investigation and             4,357               1           4,357  4.........................................       17,428
 corrective action when the results of
 laboratory assays of drug components indicate
 that the medicated feed is not in accord with
 the permissible assay limits.
225.180 requires identification, storage, and             4,357              96         418,272  0.12 (7 minutes)..........................       50,193
 inventory control of labeling in a manner that
 prevents label mix-ups and assures that
 correct labels are used for medicated feeds.
225.202 requires records of formulation,                  4,357             260       1,132,820  0.65 (39 minutes).........................      736,333
 production, and distribution of medicated
 feeds.
                                                --------------------------------------------------------------------------------------------------------
    Total......................................  ..............  ..............  ..............  ..........................................      821,382
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.


                              Table 4--Estimated Annual Recordkeeping Burden--Nonregistered Non-Licensed Mixer/Feeders \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                    Number of
                 21 CFR section                     Number of      records per    Total annual         Average burden per recordkeeper       Total hours
                                                  recordkeepers   recordkeeper       records
--------------------------------------------------------------------------------------------------------------------------------------------------------
225.142 requires procedures for identification,           3,400               4          13,600  1.........................................       13,600
 storage, and inventory control (receipt and
 use) of Type A medicated articles and Type B
 medicated feeds.
225.158 requires records of investigation and             3,400               1           3,400  4.........................................       13,600
 corrective action when the results of
 laboratory assays of drug components indicate
 that the medicated feed is not in accord with
 the permissible assay limits.
225.180 requires identification, storage, and             3,400              32         108,800  0.12 (7 minutes)..........................       13,056
 inventory control of labeling in a manner that
 prevents label mix-ups and assures that
 correct labels are used for medicated feeds.
225.202 requires records of formulation,                  3,400             260         884,000  0.33 (20 minutes).........................      291,720
 production, and distribution of medicated
 feeds.
                                                --------------------------------------------------------------------------------------------------------
    Total......................................  ..............  ..............  ..............  ..........................................      331,976
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.

    Our estimated burden for the information collection reflects an 
overall decrease of 10,435 hours and an increase of 831,545 records 
since last OMB approval. We attribute this adjustment due to an 
increase in the number of non-registered, non-licensed commercial 
medicated feed mills and decrease in non-licensed medicated feed mill 
recordkeeping the last few years.

    Dated: February 1, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-02446 Filed 2-3-23; 8:45 am]
BILLING CODE 4164-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.